at adapthealth, we believe everyone deserves a comfortable and independent life with access to products and services tailored to empower patients to live their best lives -- out of the hospital and in their homes. we are a full-service home medical equipment and respiratory company with operations in 46 states offering a breadth of clinically-focused products and services to help patients with daily activities of life including: sleep and respiratory therapy, mobility products, wound care, non-invasive ventilation and nutrition.
Company profile
Ticker
AHCO
Exchange
Website
CEO
Luke McGee
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
DFB Healthcare Acquisitions Corp.
SEC CIK
Corporate docs
Subsidiaries
ABC Medical, LLC • Absolute Respiratory Care, LLC • Access Medical, LLC • Accucare Medical Equipment, LLC • ActivStyle Holding Company • ActivStyle, LLC • AdaptHealth - Missouri LLC • AdaptHealth Holdings LLC • AdaptHealth Intermediate HoldCo LLC • AdaptHealth LLC ...
AHCO stock data
Latest filings (excl ownership)
8-K
Adapthealth Appoints Suzanne Foster As Chief Executive Officer
17 Apr 24
PRE 14A
Preliminary proxy
12 Apr 24
8-K
Departure of Directors or Certain Officers
4 Mar 24
10-K
2023 FY
Annual report
27 Feb 24
8-K
Adapthealth Corp. Announces Fourth Quarter and Full-year 2023 Results and Provides Initial 2024 Outlook
27 Feb 24
8-K
Departure of Directors or Certain Officers
27 Dec 23
S-8
Registration of securities for employees
13 Dec 23
8-K
Departure of Directors or Certain Officers
22 Nov 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Adapthealth Corp. Announces Third Quarter 2023 Results
7 Nov 23
Transcripts
AHCO
Earnings call transcript
2023 Q4
27 Feb 24
AHCO
Earnings call transcript
2023 Q3
7 Nov 23
AHCO
Earnings call transcript
2023 Q2
8 Aug 23
AHCO
Earnings call transcript
2023 Q1
9 May 23
AHCO
Earnings call transcript
2023 Q1
9 May 23
AHCO
Earnings call transcript
2022 Q4
28 Feb 23
AHCO
Earnings call transcript
2022 Q3
8 Nov 22
AHCO
Earnings call transcript
2022 Q2
9 Aug 22
AHCO
Earnings call transcript
2022 Q1
14 May 22
AHCO
Earnings call transcript
2021 Q4
26 Feb 22
Latest ownership filings
5
RICHARD A BARASCH
8 Apr 24
4
Jason A Clemens
20 Mar 24
4
James E Flynn
12 Mar 24
3
James E Flynn
8 Mar 24
4
RICHARD A BARASCH
4 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
Flynn James E
12 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
4
Shaw Rietkerk
7 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 56.14 mm | 56.14 mm | 56.14 mm | 56.14 mm | 56.14 mm | 56.14 mm |
Cash burn (monthly) | (no burn) | 4.55 mm | 162.50 mm | 31.69 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | 31.02 mm | 1.11 bn | 216.07 mm | n/a | n/a |
Cash remaining | n/a | 25.13 mm | -1.05 bn | -159.93 mm | n/a | n/a |
Runway (months of cash) | n/a | 5.5 | -6.5 | -5.0 | n/a | n/a |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 197 |
Opened positions | 36 |
Closed positions | 26 |
Increased positions | 84 |
Reduced positions | 49 |
13F shares | Current |
---|---|
Total value | 1.02 tn |
Total shares | 170.99 mm |
Total puts | 420.40 k |
Total calls | 1.57 mm |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
Flynn James E | 21.67 mm | $0.00 |
Vii GP, L.L.C. Oep | 13.82 mm | $299.86 mm |
Oep Capital Advisors | 13.82 mm | $125.75 bn |
Deerfield Management | 13.61 mm | $123.83 bn |
BLK Blackrock | 13.14 mm | $119.60 bn |
Everest Hill | 9.95 mm | $146.99 mm |
FMR | 8.83 mm | $80.38 bn |
Vanguard | 8.66 mm | $78.77 bn |
SkyKnight Capital | 8.58 mm | $78.08 bn |
SkyKnight Aero | 5.76 mm | $99.41 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Mar 24 | Jason A Clemens | Common Stock | Grant | Acquire A | No | No | 0 | 128,380 | 0.00 | 455,719 |
12 Mar 24 | Flynn James E | Class A Common Stock | Sell | Dispose S | Yes | No | 10.7 | 114,906 | 1.23 mm | 11,528,863 |
11 Mar 24 | Flynn James E | Class A Common Stock | Sell | Dispose S | Yes | No | 11.13 | 88,040 | 979.89 k | 11,643,769 |
11 Mar 24 | Flynn James E | Class A Common Stock | Sell | Dispose S | Yes | No | 10.92 | 94,567 | 1.03 mm | 11,731,809 |
8 Mar 24 | Flynn James E | Class A Common Stock | Sell | Dispose S | Yes | No | 11.03 | 4,495 | 49.58 k | 11,826,376 |
8 Mar 24 | Flynn James E | Class A Common Stock | Sell | Dispose S | Yes | No | 10.92 | 47,992 | 524.07 k | 11,830,871 |
2 Mar 24 | Barasch Richard A | Common Stock | Grant | Acquire A | No | No | 0 | 21,206 | 0.00 | 451,632 |
29 Feb 24 | Barasch Richard A | Common Stock | Payment of exercise | Dispose F | No | No | 10.23 | 8,984 | 91.91 k | 430,426 |
5 Feb 24 | Albert A. Prast | Common Stock | Grant | Acquire A | No | No | 0 | 71,339 | 0.00 | 181,083 |
News
AdaptHealth Appoints Suzanne Foster As Chief Executive Officer, Will Assume Leadership Of The Company From Interim CEO And Chairman Of The Board, Richard Barasch, On May 20, 2024
17 Apr 24
Philips (PHG) Boosts Patient Monitoring With SmartQare Deal
9 Apr 24
Peeling Back The Layers: Exploring AdaptHealth Through Analyst Insights
4 Mar 24
RBC Capital Reiterates Outperform on AdaptHealth, Maintains $13 Price Target
4 Mar 24
UBS Maintains Buy on AdaptHealth, Raises Price Target to $13
28 Feb 24
Press releases
AdaptHealth Appoints Suzanne Foster as Chief Executive Officer
17 Apr 24
ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating AdaptHealth Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
21 Mar 24
AdaptHealth Corp. to Participate in the Barclays 26th Annual Global Healthcare Conference
4 Mar 24
AdaptHealth Corp. to Participate in the 3rd Annual Jefferies Value Based Care Summit
1 Mar 24
AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook
27 Feb 24